EGFR inhibitor_Protein Tyrosine Kinase_Chem Catch, Global Inhibitor Store

Home About Us Newest Recommend

Search

Search Type： Product Name, Cat No., CAS No., Chemical Name

Your Position: Home > Protein Tyrosine Kinase > EGFR inhibitor

All Categories

Angiogenesis

Apoptosis

Autophagy

Cell Cycle

Cytoskeletal Signaling

DNA Damage

Endocrinology & Hormones

Epigenetics

GPCR & G Protein

Immunology & Inflammation

JAK/STAT

kit

MAPK

Metabolism

Microbiology

Neuronal Signaling

NF-κB

Others

PI3K/Akt/mTOR

Proteases

Protein Tyrosine Kinase

Stem Cells & Wnt

TGF-beta/Smad

Transmembrane Transporters

Ubiquitin

Goods List

Cat#

Goods Name

description

EAI045 is an allosteric inhibitor that targets selected drug-resistant EGFR mutants but spares the wild-type receptor.

Dacomitinib (PF299804, PF299)

Dacomitinib (PF299804, PF299) is a potent, irreversible pan-ErbB inhibitor, mostly to EGFR with IC50 of 6 nM in a cell-free assay, effective against NSCLCs with EGFR or ERBB2 mutations (resistant to gefitinib) as well as those harboring the

CNX-2006 is a novel irreversible mutant-selective EGFR inhibitor with IC50 of < 20 nM, with very weak inhibition at wild-type EGFR.

CL-387785 (EKI-785)

CL-387785 (EKI-785) is an irreversible, and selective EGFR inhibitor with IC50 of 370 pM.

Chrysophanic Acid

Chrysophanic acid (Chrysophanol), a natural anthraquinone isolated from Dianella longifolia, is a EGFR/mTOR pathway inhibitor.

Canertinib (CI-1033)

Canertinib (CI-1033) is a pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM, no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4. Phase 3.

Butein, a plant polyphenol isolated from Rhus verniciflua, is able to inhibit the activation of protein tyrosine kinase, NF-κB and STAT3, also inhibits EGFR.

AZD3759 is a potent, oral active, CNS-penetrant EGFR inhibitor with IC50 of 0.3 nM, 0.2 nM, and 0.2 nM for EGFR (WT), EGFR (L858R), and EGFR (exon 19Del), respectively. Phase 1.

AZ5104, the demethylated metabolite of AZD-9291, is a potent EGFR inhibitor with IC50 of <1 nm, 6 1 and 25 nm for egfr (l858r>

AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, also effective in mutation EGFR T790M/L858R, more potent to ErbB2-overexpressing cells, 3000-fold selective for ErbB family than other kinases.

Chem Catch products are for research use only. Not for human use. We do not sell to patients.

沪ICP备16042327号-2